Piper Sandler & Co’s Insulet PODD Stock Holding History

Piper Sandler & Co’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-16,500	Closed	-$550K	–	114
2015 Q1	$550K	Buy	+16,500	New	+$557K	0.23%	41

Other funds holding PODD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Piper Sandler & Co's PODD Position: Q2 2015 in Review

Piper Sandler & Co sold out of Insulet (PODD) in Q2 2015, closing a stake of 16,500 shares — an estimated $550K sold.

Piper Sandler & Co first reported a position in PODD in Q1 2015 and held it in 1 quarter. The position peaked at $550K in Q1 2015. 153 funds tracked by Wall St. Rank hold PODD as of Q2 2015.

Piper Sandler & Co reported no remaining Insulet position as of Q2 2015 after selling out during the quarter.
Piper Sandler & Co sold 16,500 Insulet shares in Q2 2015, an estimated $550K.
Piper Sandler & Co first reported a position in Insulet in Q1 2015 and held it in 1 quarter.
Piper Sandler & Co's Insulet position peaked at $550K in Q1 2015.
153 funds tracked by Wall St. Rank held Insulet as of Q2 2015.

Based on Piper Sandler & Co's 13F filing for Q2 2015, filed 14 Aug 2015.